MSMoritz von Stosch

Moritz von Stosch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Moritz von Stosch has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Self-Driving Development of Perfusion Processes for Monoclonal Antibody Production

    by Claudio Müller, Thomas Vuillemin, Chethana Janardhana Gadiyar, Jean-Marc Bielser, Jonathan Souquet, Alessandro Fagnani, Michael Sokolov, Moritz von Stosch, Fabian Feidl, Alessandro Butté, et al.

    It is essential to increase the number of autonomous agents bioprocess development for biopharma innovation to shorten time and resource utilization in the path from product to process. While robotics and machine learning have significantly accelerated drug discovery and initial screening, the later stages of development have seen improvement only in the experimental automation but lack advanced computational tools for experimental planning and execution. For instance, during development of new monoclonal antibodies, the search for optimal upstream conditions (feeding strategy, pH, temperature, media composition, etc.) is often performed in highly advanced high-throughput (HT) mini-bioreactor systems. However, the integration of machine learning tools for experiment design and operation in these systems remains underdeveloped. In this study, we introduce an integrated framework composed by a Bayesian experimental design algorithm, a cognitive digital twin of the cultivation system, and an advanced 24 parallel mini-bioreactor perfusion experimental setup. The result is an autonomous experimental machine capable of 1. embedding existing process knowledge, 2. learning during experimentation, 3. Using information from similar processes, 4. Notifying events in the near future, and 5. Autonomously operating the parallel cultivation setup to reach challenging objectives. As a proof of concept, we present experimental results of 27 days long cultivations operated by an autonomous software agent reaching challenging goals as are increasing the VCV and maximizing the viability of the cultivation up to its end.

  • Open Access

    Giving the cells what they need when they need it: Biosensor‐based feeding control

    by Romain Kinet, Anne Richelle, Michael Colle, Didier Demaegd, Moritz von Stosch, Matthew Sanders, Hannah Sehrt, Frank Delvigne, Philippe Goffin

    “Giving the cells exactly what they need, when they need it” is the core idea behind the proposed bioprocess control strategy: operating bioprocess based on the physiological behavior of the microbial population rather than exclusive monitoring of environmental parameters. We are envisioning to achieve this through the use of genetically encoded biosensors combined with online flow cytometry (FCM) to obtain a time‐dependent “physiological fingerprint” of the population. We developed a biosensor based on the glnA promoter (glnAp) and applied it for monitoring the nitrogen‐related nutritional state of Escherichia coli. The functionality of the biosensor was demonstrated through multiple cultivation runs performed at various scales—from microplate to 20 L bioreactor. We also developed a fully automated bioreactor—FCM interface for on‐line monitoring of the microbial population. Finally, we validated the proposed strategy by performing a fed‐batch experiment where the biosensor signal is used as the actuator for a nitrogen feeding feedback control. This new generation of process control, —based on the specific needs of the cells, —opens the possibility of improving process development on a short timescale and therewith, the robustness and performance of fermentation processes.


  • Knowledge transfer across cell lines using hybrid Gaussian process models with entity embedding vectors

    by Clemens Hutter, Moritz von Stosch, Mariano N. Cruz Bournazou, Alessandro Butté

    To date, a large number of experiments are performed to develop a biochemical process. The generated data is used only once, to take decisions for development. Could we exploit data of already developed processes to make predictions for a novel process, we could significantly reduce the number of experiments needed. Processes for different products exhibit differences in behaviour, typically only a subset behave similar. Therefore, effective learning on multiple product spanning process data requires a sensible representation of the product identity. We propose to represent the product identity (a categorical feature) by embedding vectors that serve as input to a Gaussian process regression model. We demonstrate how the embedding vectors can be learned from process data and show that they capture an interpretable notion of product similarity. The improvement in performance is compared to traditional one‐hot encoding on a simulated cross product learning task. All in all, the proposed method could render possible significant reductions in wet‐lab experiments.


  • A mathematical model of decision making for investment in process modeling & simulation

    by Christos Varsakelis, Moritz von Stosch, Sandrine Dessoy, Alexander Pysik

    We propose a mathematical model for investment evaluation of process modeling on both monetary and diffusion-of-innovation fronts. Our methodology builds upon Discounted Cash Flow analysis and Bayesian inference and utilizes the Rogers diffusion of innovation paradigm for computing lower expected returns.


  • Analysis of Transformed Upstream Bioprocess Data Provides Insights into Biological System Variation

    by Anne Richelle, Boung Wook Lee, Rui M. C. Portela, Jonathan Raley, Moritz von Stosch

    In recent years, multivariate data analysis (MVDA) and modeling approaches have found increasing applications for upstream bioprocess studies (e.g., monitoring, development, optimization, scale‐up, etc.). Many of these studies look at variations in the concentrations of metabolites and cell‐based measurements. However, these measures are subject to system inherent variations (e.g., changes in metabolic activity) but also intentional operational changes. It is proposed to perform MVDA and modeling on data representative of the underlying biological system operation, that is, the specific rates, which are per se independent of the scale, operational strategy (e.g., batch, fed‐batch), and biomass content. Two industrial case studies are highlighted to showcase the approach: one is HEK medium performance comparison study and the other is CHO scale‐up/‐down study. It is shown that analyzing processes in this way reveals insights into behavior of the underlying biological system, which cannot to the same degree be deducted from the analysis of concentrations.


  • Open Access

    Working within the Design Space: Do Our Static Process Characterization Methods Suffice?

    by Moritz von Stosch, René Schenkendorf, Geoffroy Geldhof, Christos Varsakelis, Marco Mariti, Sandrine Dessoy, Annick Vandercammen, Alexander Pysik, Matthew Sanders

    The Process Analytical Technology initiative and Quality by Design paradigm have led to changes in the guidelines and views of how to develop drug manufacturing processes. On this occasion the concept of the design space, which describes the impact of process parameters and material attributes on the attributes of the product, was introduced in the ICH Q8 guideline. The way the design space is defined and can be presented for regulatory approval seems to be left to the applicants, among who at least a consensus on how to characterize the design space seems to have evolved. The large majority of design spaces described in publications seem to follow a “static” statistical experimentation and modeling approach. Given that temporal deviations in the process parameters (i.e., moving within the design space) are of a dynamic nature, static approaches might not suffice for the consideration of the implications of variations in the values of the process parameters. In this paper, different forms of design space representations are discussed and the current consensus is challenged, which in turn, establishes the need for a dynamic representation and characterization of the design space. Subsequently, selected approaches for a dynamic representation, characterization and validation which are proposed in the literature are discussed, also showcasing the opportunity to integrate the activities of process characterization, process monitoring and process control strategy development.


  • A bootstrap-aggregated hybrid semi-parametric modeling framework for bioprocess development

    by José Pinto, Cristiana Rodrigues de Azevedo, Rui Oliveira, Moritz von Stosch

    Hybrid semi-parametric modeling, combining mechanistic and machine-learning methods, has proven to be a powerful method for process development. This paper proposes bootstrap aggregation to increase the predictive power of hybrid semi-parametric models when the process data are obtained by statistical design of experiments. A fed-batch Escherichia coli optimization problem is addressed, in which three factors (biomass growth setpoint, temperature, and biomass concentration at induction) were designed statistically to identify optimal cell growth and recombinant protein expression conditions. Synthetic data sets were generated applying three distinct design methods, namely, Box–Behnken, central composite, and Doehlert design. Bootstrap-aggregated hybrid models were developed for the three designs and compared against the respective non-aggregated versions. It is shown that bootstrap aggregation significantly decreases the prediction mean squared error of new batch experiments for all three designs. The number of (best) models to aggregate is a key calibration parameter that needs to be fine-tuned in each problem. The Doehlert design was slightly better than the other designs in the identification of the process optimum. Finally, the availability of several predictions allowed computing error bounds for the different parts of the model, which provides an additional insight into the variation of predictions within the model components.


  • Exploiting mAb structure characteristics for a directed QbD implementation in early process development

    by Micael Karlberg, Moritz von Stosch, Jarka Glassey

    In today’s biopharmaceutical industries, the lead time to develop and produce a new monoclonal antibody takes years before it can be launched commercially. The reasons lie in the complexity of the monoclonal antibodies and the need for high product quality to ensure clinical safety which has a significant impact on the process development time. Frameworks such as quality by design are becoming widely used by the pharmaceutical industries as they introduce a systematic approach for building quality into the product. However, full implementation of quality by design has still not been achieved due to attrition mainly from limited risk assessment of product properties as well as the large number of process factors affecting product quality that needs to be investigated during the process development. This has introduced a need for better methods and tools that can be used for early risk assessment and predictions of critical product properties and process factors to enhance process development and reduce costs. In this review, we investigate how the quantitative structure–activity relationships framework can be applied to an existing process development framework such as quality by design in order to increase product understanding based on the protein structure of monoclonal antibodies. Compared to quality by design, where the effect of process parameters on the drug product are explored, quantitative structure–activity relationships gives a reversed perspective which investigates how the protein structure can affect the performance in different unit operations. This provides valuable information that can be used during the early process development of new drug products where limited process understanding is available. Thus, quantitative structure–activity relationships methodology is explored and explained in detail and we investigate the means of directly linking the structural properties of monoclonal antibodies to process data. The resulting information as a decision tool can help to enhance the risk assessment to better aid process development and thereby overcome some of the limitations and challenges present in QbD implementation today.


  • Open Access

    Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study

    by Moritz von Stosch, Jan-Martijn Hamelink, Rui Oliveira

    Process understanding is emphasized in the process analytical technology initiative and the quality by design paradigm to be essential for manufacturing of biopharmaceutical products with consistent high quality. A typical approach to developing a process understanding is applying a combination of design of experiments with statistical data analysis. Hybrid semi-parametric modeling is investigated as an alternative method to pure statistical data analysis. The hybrid model framework provides flexibility to select model complexity based on available data and knowledge. Here, a parametric dynamic bioreactor model is integrated with a nonparametric artificial neural network that describes biomass and product formation rates as function of varied fed-batch fermentation conditions for high cell density heterologous protein production with E. coli. Our model can accurately describe biomass growth and product formation across variations in induction temperature, pH and feed rates. The model indicates that while product expression rate is a function of early induction phase conditions, it is negatively impacted as productivity increases. This could correspond with physiological changes due to cytoplasmic product accumulation. Due to the dynamic nature of the model, rational process timing decisions can be made and the impact of temporal variations in process parameters on product formation and process performance can be assessed, which is central for process understanding.